- Home
- ADCT vs SRV Comparison
ADCT vs SRV Comparison
Compare ADCT & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- SRV
- Stock Information
- Founded
- ADCT 2011
- SRV 2007
- Country
- ADCT Switzerland
- SRV United States
- Employees
- ADCT N/A
- SRV N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- SRV Finance Companies
- Sector
- ADCT Health Care
- SRV Finance
- Exchange
- ADCT Nasdaq
- SRV Nasdaq
- Market Cap
- ADCT 143.1M
- SRV 136.9M
- IPO Year
- ADCT 2020
- SRV N/A
- Fundamental
- Price
- ADCT $1.63
- SRV $45.87
- Analyst Decision
- ADCT Strong Buy
- SRV
- Analyst Count
- ADCT 5
- SRV 0
- Target Price
- ADCT $8.00
- SRV N/A
- AVG Volume (30 Days)
- ADCT 493.2K
- SRV 33.9K
- Earning Date
- ADCT 03-12-2025
- SRV 01-01-0001
- Dividend Yield
- ADCT N/A
- SRV 13.38%
- EPS Growth
- ADCT N/A
- SRV N/A
- EPS
- ADCT N/A
- SRV N/A
- Revenue
- ADCT $70,717,000.00
- SRV N/A
- Revenue This Year
- ADCT $6.81
- SRV N/A
- Revenue Next Year
- ADCT $11.23
- SRV N/A
- P/E Ratio
- ADCT N/A
- SRV N/A
- Revenue Growth
- ADCT N/A
- SRV N/A
- 52 Week Low
- ADCT $1.39
- SRV $30.73
- 52 Week High
- ADCT $5.38
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- ADCT 46.49
- SRV 47.40
- Support Level
- ADCT $1.55
- SRV $45.81
- Resistance Level
- ADCT $1.73
- SRV $47.96
- Average True Range (ATR)
- ADCT 0.12
- SRV 0.86
- MACD
- ADCT 0.03
- SRV -0.09
- Stochastic Oscillator
- ADCT 63.16
- SRV 45.40
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.